Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
Con tacts (Pharm): Com mer cial Op er a tions:<br />
Endre Nemeth (Sales), Laszlo Madarasz (Mar ket -<br />
ing); Gen eral Con tact: Laszlo Madarasz<br />
Phar ma ceu ti cal Sales: US$ 30-35 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 70-75%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 75-80%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
80-85%<br />
Prin ci pal Prod ucts:<br />
NEOCITRAN (cold prep a ra tion with out anti-in fec -<br />
tive)<br />
VENORUTON (var i cose ther apy sys temic; var i -<br />
cose ther apy top i cal)<br />
FENISTIL (antipruritic; an ti his ta mine sys temic)<br />
VOLTAREN EMULGEL (antirheumatic top i cal)<br />
MEBUCAIN (throat prep a ra tion)<br />
Ther a peu tic Range:<br />
cough and cold prep a ra tions 39%<br />
antivaricosis/antihemorrhoidal prep a ra tions<br />
13%<br />
anti rheu ma tics top i cal 10%<br />
na sal prep a ra tions 8%<br />
throat prep a ra tions 7%<br />
Lead ing Dose Forms:<br />
pow ders/gran ules 32%<br />
gels/sols 19%<br />
liq uids 14%<br />
tab lets 12%<br />
spe cial solid forms 8%<br />
SANDOZ<br />
Full Name: Sandoz Hun gary L.L.C.<br />
Street Ad dress: H-1034 Bu da pest, Timar ut. 20.<br />
Tel: +36 1 430-2890<br />
Fax: +36 1 430-2899<br />
Home Page: www.sandoz.hu<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 50-55 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 30-35%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 45-50%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
OMEPRAZOL HEXAL (antiulcerant)<br />
DICLAC (antirheumatic non-steroidal;<br />
antirheumatic top i cal)<br />
CAL CIUM-SANDOZ (cal cium prod uct)<br />
ACC (ex pec to rant)<br />
CURAM (pen i cil lin broad spec trum)<br />
Ther a peu tic Range:<br />
antibacterials sys temic 15%<br />
ant ac ids/antiflatulents/antiulcerants 13%<br />
psychoanaleptics 7%<br />
lipid-reg u lat ing/antiatheroma prep a ra tions 7%<br />
an al ge sics 6%<br />
Lead ing Dose Forms:<br />
coated tab lets 36%<br />
tab lets 25%<br />
cap sules 22%<br />
pow ders/gran ules 4%<br />
liq uids 3%<br />
INDIA<br />
CHIRON<br />
Full Name: Chiron Behring Vac cines Pri vate Lim -<br />
ited<br />
Street Ad dress: 501 Shree Amba Shanti Cham -<br />
bers, Andheri Kurla Road, (opp. The Leela),<br />
Andheri East 400059, Mumbai<br />
Tel: +91 22 56930812/0810<br />
Fax: +91 22 56930813<br />
Email: info@chironvaccines.com<br />
Home Page: www.novartis.co.in<br />
CHIRON BEHRING VAC CINES<br />
Full Name: Chiron Behring Vac cines Pri vate Ltd<br />
Street Ad dress: 501 Shree Amba Shanti Cham -<br />
bers, Maharashtra<br />
Email: info@chironvaccines.com<br />
NOVARTIS<br />
Full Name: Novartis In dia Lim ited<br />
Street Ad dress: Royal In sur ance Build ing, 6th<br />
Floor, 14, J Tata Road, Mumbai 400020<br />
Tel: +91 22 22851111<br />
Fax: +91 22 22853720<br />
Home Page: www.novartis.co.in<br />
De scrip tion: De vel oper, man u fac turer, for mu la -<br />
tor, packager/as sem bler, im porter, ex porter, dis -<br />
trib u tor, pro moter, sales/detailer. Prod uct ranges<br />
in clude: phar ma ceu ti cal prod ucts (branded, pre -<br />
scrip tion), hos pi tal pharmaceuticals, in ter me di -<br />
ates, den tal prod ucts, di etetic/nu tri tional<br />
prod ucts, oph thal mic prod ucts. Es tab lished 1997.<br />
Di vi sions In clude: Pharma; Sandoz; Consumer<br />
Health; Animal Health.<br />
Con tacts (Pharm): Chair man: Ranjit Shahani;<br />
Com mer cial Op er a tions: Anit Matai, Yucal Sikri,<br />
K.N. Chandrasekaran; Mar ket Re search: Deep<br />
Ajmani; Gen eral Con tact: Deep Ajmani<br />
Sub sid iary of: Novartis, Swit zer land (51%)<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 176
Change language